MHIM
TEVA icon

MacNealy Hoover Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

MacNealy Hoover Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-62,675
Closed -$983K – 72
2019
Q1 		$983K Buy
62,675
+1,900
+3% +$33.5K 0.76% 45
2018
Q4 		$937K Sell
60,775
-4,975
-8% -$102K 0.81% 44
2018
Q3 		$1.42M Sell
65,750
-200
-0.3% -$4.64K 1.04% 41
2018
Q2 		$1.6M Sell
65,950
-1,150
-2% -$23.5K 1.25% 31
2018
Q1 		$1.15M Sell
67,100
-1,100
-2% -$21.5K 0.92% 42
2017
Q4 		$1.29M Sell
68,200
-4,825
-7% -$72.6K 0.93% 41
2017
Q3 		$1.28M Buy
73,025
+62,525
+595% +$1.41M 0.92% 41
2017
Q2 		$349K Buy
10,500
+445
+4% +$13.8K 0.27% 66
2017
Q1 		$323K Sell
10,055
-1,700
-14% -$58K 0.25% 65
2016
Q4 		$426K Sell
11,755
-1,425
-11% -$56.9K 0.33% 61
2016
Q3 		$607K Hold
13,180
– – 0.49% 56
2016
Q2 		$662K Buy
13,180
+250
+2% +$13.3K 0.53% 57
2016
Q1 		$692K Buy
12,930
+75
+0.6% +$4.4K 0.56% 56
2015
Q4 		$844K Buy
12,855
+200
+2% +$12.4K 0.71% 52
2015
Q3 		$715K Hold
12,655
– – 0.64% 56
2015
Q2 		$748K Sell
12,655
-200
-2% -$12.3K 0.61% 56
2015
Q1 		$801K Hold
12,855
– – 0.69% 55
2014
Q4 		$739K Sell
12,855
-200
-2% -$11.1K 0.63% 56
2014
Q3 		$702K Sell
13,055
-250
-2% -$13.2K 0.62% 59
2014
Q2 		$698K Sell
13,305
-300
-2% -$15.3K 0.61% 55
2014
Q1 		$719K Sell
13,605
-600
-4% -$27.7K 0.64% 53
2013
Q4 		$569K Buy
+14,205
New +$559K 0.53% 59

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MacNealy Hoover Investment Management's TEVA Position: Q2 2019 in Review

MacNealy Hoover Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 62,675 shares — an estimated $983K sold.

MacNealy Hoover Investment Management first reported a position in TEVA in Q4 2013 and held it in 22 quarters. The position peaked at $1.6M in Q2 2018. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • MacNealy Hoover Investment Management reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • MacNealy Hoover Investment Management sold 62,675 Teva Pharmaceuticals shares in Q2 2019, an estimated $983K.
  • MacNealy Hoover Investment Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 22 quarters.
  • MacNealy Hoover Investment Management's Teva Pharmaceuticals position peaked at $1.6M in Q2 2018.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on MacNealy Hoover Investment Management's 13F filing for Q2 2019, filed 9 Jul 2019.